EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?

Andrea Fa iD, Denise M Danos, Lauren Maniscalco iD, Yong Yi, Xiao-Cheng Wu, Mary A Maluccio, Quyen D Chu, John M Lyons

Cancers · 24.05.2023 · 15 (11) · 2892

DOI: 10.3390/cancers15112892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 24.05.2023. Verfasst von Andrea Fa und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, LSU Health Sciences Center-New Orleans, New Orleans, LA 70112, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute, Surveillance, Epidemiology, and End Results (SEERS) Program, CDC’s National Program of Cancer Registries.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a male-dominated disease. Currently, gender differences remain incompletely defined. Data from the state tumor registry were used to investigate differences in demographics, comorbidities, treatment patterns, and cancer-specific survival (HSS) among HCC patients according to gender. Additional analyses were performed to evaluate racial differences among women with HCC. 2627 patients with HCC were included; 498 (19%) were women. Women were mostly white (58%) or African American (39%)—only 3.8% were of another or unknown race. Women were older (65.1 vs. 61.3 years), more obese (33.7% vs. 24.2%), and diagnosed at an earlier stage (31.7% vs. 28.4%) than men. Women had a lower incidence of liver associated comorbidities (36.1% vs. 43%), and more often underwent liver-directed surgery (LDS; 27.5% vs. 22%). When controlling for LDS, no survival differences were observed between genders. African American women had similar HSS rates compared to white women (HR 1.14 (0.91,1.41), p = 0.239) despite having different residential and treatment geographical distributions. African American race and age >65 were predictive for worse HSS in men, but not in women. Overall, women with HCC undergo more treatment options—likely because of the earlier stage of the cancer and/or less severe underlying liver disease. However, when controlling for similar stages and treatments, HCC treatment outcomes were similar between men and women. African American race did not appear to influence outcomes among women with HCC as it did in men.

Schlagwörter

Stichwörter der Autor:innen

Louisianadisparitieshepatocellular cancerincidencewomen

Autor:innen und Institutionen

  • School of Medicine, LSU Health Sciences Center-New Orleans, New Orleans, LA 70112, USA.
  • School of Public Health, LSU Health Science Center-New Orleans, New Orleans, LA 70112, USA.
  • Louisiana Tumor Registry, School of Public Health, LSU Health Science Center-New Orleans, New Orleans, LA 70112, USA.
  • Orlando Health Cancer Institute, Orlando, FL 32806, USA.
  • Our Lady of the Lake Regional Medical Center, Baton Rouge, LA 70808, USA.

ORCID-Profile: Andrea Fa, Lauren Maniscalco

Förderung

  • National Cancer Institute
  • Surveillance, Epidemiology, and End Results (SEERS) Program
  • CDC’s National Program of Cancer Registries

Zitieren

APA

Fa, A., Danos, D. M., Maniscalco, L., Yi, Y., Wu, X. C., Maluccio, M. A., Chu, Q. D., & Lyons, J. M. (2023). Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?. Cancers, 15(11), 2892. https://doi.org/10.3390/cancers15112892

Vancouver

Fa A, Danos DM, Maniscalco L, Yi Y, Wu XC, Maluccio MA, et al. Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?. Cancers. 2023;15(11):2892. doi:10.3390/cancers15112892

BibTeX
@article{Fa2023,
  author = {Fa, Andrea and Danos, Denise M and Maniscalco, Lauren and Yi, Yong and Wu, Xiao-Cheng and Maluccio, Mary A and Chu, Quyen D and Lyons, John M},
  title = {Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {2892},
  doi = {10.3390/cancers15112892}
}
Kostenlos starten →